Ilaprazole
Proton pump inhibitor (PPI)
What it is used for
Duodenal ulcers, benign gastric ulcers, and prevention of peptic ulcers associated with NSAIDs, reflux oesophagitis, Zollinger-Ellison syndrome Clinical selection for Ilaprazole should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Proton pump inhibitor (PPI). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Use lowest effective dose/shortest duration. Long-term: hypomagnesaemia, B12 deficiency, increased GI infection risk, fracture signal, fundic polyps. Masking of malignancy — investigate alarm features.
Possible side effects
Candidiasis, GI disturbances, skin rashes, photosensitivity, stomatitis blood dyscrasia, hypersensitivity, CNS effects, paraesthesia, malaise, alopecia, muscle weakness, myalgia, peripheral edema, gynecomastia, hepatitis.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.